Influenza News

Phase 3 clinical trial data of GlaxoSmithKline’s quadrivalent influenza vaccine are showing “superior immunogenicity for the additional B strain” over the trivalent influenza vaccine, according to results published online.

Intensified surveillance in both humans and animals will answer important questions about the H7N9 virus that is currently affecting humans in China, according to Timothy M. Uyeki, MD, and Nancy J Cox, PhD, both of the Influenza Division of the CDC’s National Center for Immunization and Respiratory Diseases.

The World Health Organization has reported 10 more confirmed cases of influenza A(H7N9) in China, bringing the number of cases to 38. There have been 10 deaths.

It is still too early to make any predictions about what will happen with the novel influenza A(H7N9) virus this fall, according to Michael Shaw, PhD, associate director of Laboratory Science for the CDC’s Influenza Division.

Chinese health officials have reported a total of 24 cases of human infection with the novel avian influenza virus A(H7N9) as of April 8. The death toll is seven, according to Michael Shaw, PhD, associate director of laboratory science for the CDC’s Influenza Division.

Significant improvements in global surveillance and notification systems made after the Sept. 11, 2001, terrorist attacks led to earlier identification and characterization of the 2009 H1N1 outbreak, according to a new report.

Significant improvements in global surveillance and notification systems made after the Sept. 11, 2001, terrorist attacks led to earlier identification and characterization of the 2009 H1N1 outbreak, according to a new report.

An avian influenza virus, A(H7N9), has infected seven people in China, according to the World Health Organization.

Data from a meta-analysis show that there may be a slight risk for Guillain-Barré syndrome associated with the influenza A (H1N1) 2009 monovalent inactivated vaccine.

The Vaccines and Related Biological Products Advisory Committee accepted the recommendations of WHO for the components of the 2013-2014 seasonal influenza vaccine, which replaces the influenza A (H3N2) and influenza B strains used this past season.